[Supplementary Statement on IVOM Drugs for the Treatment of Diabetic Macular Edema with Foveal Involvement - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].
出版信息
Klin Monbl Augenheilkd. 2023 Mar;240(3):327-331. doi: 10.1055/a-2009-5833. Epub 2023 Mar 28.
PMID:36977429
Abstract
摘要
相似文献
1
[Supplementary Statement on IVOM Drugs for the Treatment of Diabetic Macular Edema with Foveal Involvement - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].[关于治疗累及黄斑中心凹的糖尿病性黄斑水肿的玻璃体内注射药物补充声明——德国眼科学会（DOG）、德国视网膜协会（RG）和德国眼科医生专业协会（BVA）声明。2022年10月28日状况]
Klin Monbl Augenheilkd. 2023 Mar;240(3):327-331. doi: 10.1055/a-2009-5833. Epub 2023 Mar 28.
2
[Supplementary statement on IVOM drugs for the treatment of diabetic macular edema with foveal involvement : Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status 28 October 2022].[关于用于治疗累及黄斑中心凹的糖尿病性黄斑水肿的玻璃体内注射药物的补充声明：德国眼科学会（DOG）、德国视网膜学会（RG）和德国眼科医生专业协会（BVA）声明。2022年10月28日状态]
Ophthalmologie. 2023 Mar;120(3):273-275. doi: 10.1007/s00347-022-01782-5. Epub 2022 Dec 20.
3
[Supplementary statement of the German Ophthalmological Society (DOG), the Retinological Society (RG) and the Professional Association of German Ophthalmologists (BVA) on treatment of proliferative diabetic retinopathy : Status November 2019].[德国眼科学会（DOG）、视网膜病学会（RG）和德国眼科医生专业协会（BVA）关于增殖性糖尿病视网膜病变治疗的补充声明：2019年11月状况]
Ophthalmologe. 2020 Aug;117(8):755-759. doi: 10.1007/s00347-020-01116-3.
4
Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019.德国眼科学会、德国视网膜学会和德国眼科医生专业协会关于糖尿病性黄斑水肿治疗的声明：日期为2019年8月。
Ophthalmologe. 2021 Jan;118(Suppl 1):40-67. doi: 10.1007/s00347-020-01244-w.
5
[Supplementary statement of the German Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on laser treatment of drusen in age-related macular degeneration (AMD) : Status October 2018].[德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于年龄相关性黄斑变性（AMD）中玻璃疣激光治疗的补充声明：2018年10月状况]
Ophthalmologe. 2019 Feb;116(2):138-143. doi: 10.1007/s00347-018-0834-6.
6
Statement of the Professional Association of Ophthalmologists in Germany (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Status 18 October 2021.德国眼科医生专业协会（BVA）、德国眼科学会（DOG）和德国视网膜协会（RG）关于中心性浆液性脉络膜视网膜病变的声明：2021年10月18日的情况
Ophthalmologie. 2022 Jul;119(Suppl 2):108-122. doi: 10.1007/s00347-022-01614-6. Epub 2022 Apr 6.
7
[Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration - Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Asscociation of Ophthalmologists (BVA). Stand 15.10.2022].[新生血管性年龄相关性黄斑变性的抗VEGF治疗——德国眼科学会（DOG）、德国视网膜学会（RG）和德国眼科医生专业协会（BVA）声明。2022年10月15日]
Klin Monbl Augenheilkd. 2023 Feb;240(2):180-189. doi: 10.1055/a-1998-8890. Epub 2023 Feb 22.
8
[Pseudophakic Cystoid Macular Edema - Statement of the German Society of Ophthalmology, the German Retina Society and the German Professional Association of Ophthalmologists. Status 22 October 2022].[人工晶状体眼黄斑囊样水肿——德国眼科学会、德国视网膜学会和德国眼科医生专业协会声明。2022年10月22日状态]
Klin Monbl Augenheilkd. 2023 Mar;240(3):316-326. doi: 10.1055/a-2019-9748. Epub 2023 Mar 28.
9
[Statement of the Professional Association of Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the Retinological Society (RG) on intravitreal treatment of vision-reducing macular edema by retinal vein occlusion : Treatment strategies, status 24 April 2018].[眼科医生专业协会（BVA）、德国眼科学会（DOG）和视网膜病学会（RG）关于视网膜静脉阻塞导致视力下降性黄斑水肿的玻璃体腔内治疗声明：治疗策略，2018年4月24日现状]
Ophthalmologe. 2018 Oct;115(10):842-854. doi: 10.1007/s00347-018-0775-0.
10
[Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the Professional Association of German Ophthalmologists (BVA) on the therapeutic use of voretigene neparvovec-rzyl (Luxturna™) in ophthalmology : Situation January 2019].[德国眼科学会（DOG）、德国视网膜学会（RG）和德国眼科医生专业协会（BVA）关于眼科中使用voretigene neparvovec-rzyl（Luxturna™）进行治疗的声明：2019年1月的情况]
Ophthalmologe. 2019 Jun;116(6):524-533. doi: 10.1007/s00347-019-0885-3.
Zotero 插件